IMLYGIC® (talimogene laherparepvec) is a prescription medication injected on the skin, beneath the skin, or in your lymph glands to treat a type of skin cancer called melanoma when it can no longer be surgically removed. IMLYGIC® may not help you live longer and may not shrink canc…Read More
IMLYGIC® (talimogene laherparepvec) is a prescription …Read More
This information is intended for US healthcare professionals only.
If you are a healthcare professional, click to continue.
Continue to IMLYGIC® for professionals
Recurrent melanoma lesions after prior surgery
Representative image
IMLYGIC® is the first and only FDA-approved viral therapy that is injected directly into melanoma tumors.1,2 There, it multiplies inside the cancer cells and destroys them.* So if you’re ready to take the fight to your melanoma, talk to your doctor about IMLYGIC®.
*Exactly how IMLYGIC® works is not known.1
IMPORTANT SAFETY INFORMATION
What is IMLYGIC® used for?
IMLYGIC® (talimogene laherparepvec) is a prescription medication used to treat a type of skin cancer called melanoma when it is on your skin or in your lymph glands.
IMLYGIC® may not help you live longer and may not shrink cancer in your organs (for example, lung or liver).
What is IMLYGIC® made from and how is it given?
Who should not take IMLYGIC®?
You should not get IMLYGIC® if you are pregnant or have a weakened immune system (for example, an immune deficiency, blood or bone marrow cancer, steroid use, or HIV/AIDS).
What should you tell your doctor before getting IMLYGIC®?
The IMLYGIC® virus can spread to other areas of your body or to your close contacts (household members, caregivers, sex partners, or persons sharing the same bed). Do the following to avoid spreading IMLYGIC® to other areas of your body or to your close contacts. You should share this information with them:
What are the possible side effects of IMLYGIC®?
If you would like more information, talk with your doctor.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or
call 1-800-FDA-1088.
Please see full Prescribing Information and Medication Guide for more information about IMLYGIC®.
Indication and Limitations of Use
IMLYGIC® (talimogene laherparepvec) is a prescription medication injected on the skin, beneath the skin, or in your lymph glands, to treat a type of skin cancer called melanoma when it can no longer be surgically removed.
IMLYGIC® may not help you live longer and may not shrink cancer in your organs (for example, lung or liver).
IMPORTANT SAFETY INFORMATION
Indication and Limitations of Use
What is IMLYGIC® used for? IMLYGIC® (talimogene laherparepvec) is a prescription medication used to treat a type of skin cancer called melanoma when it is on your skin or in your lymph glands. IMLYGIC® may not help you live longer and may not shrink cancer in your organs (for example, lung or liver).
References:
1. | IMLYGIC® (talimogene laherparepvec) Prescribing Information, BioVex, Inc., a subsidiary of Amgen, Inc. |
2. | FDA approves first oncolytic virus therapy: Imlygic for melanoma. Oncology Times. https://journals.lww.com/oncology-times/Fulltext/2015/12100/FDA_Approves_First_Oncolytic_Virus_Therapy_.27.aspx. Accessed March 15, 2018. |